ACVRL1 and hereditary hemorrhagic telangiectasia: Hereditary hemorrhagic telangiectasia (HHT) gene variants in the activin receptor-like kinase 1 (ACVRL1) [12] and endoglin (ENG) [13] have been identified in PAH patients.